Nanomaterials for Cancer Diagnostics and Therapeutics View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2010-2016

FUNDING AMOUNT

11537960 USD

ABSTRACT

Nanotechnology has enormous potential for creating innovative cancer diagnostics and therapeutics. This application proposes to establish a new Northwestern University (NU)-based CCNE comprised of a partnership between the Robert H. Lurie Comprehensive Cancer Center and the International Institute for Nanotechnology. This partnership will leverage and build upon significant existing resources, relationships, and traditions of cross-disciplinary collaborations. NU is one of the few universities with the required physical infrastructure and intellectual capacity, a demonstrated track record of research success and technology transfer in nanotechnology, and established links between nanoscientists and cancer researchers to successfully achieve the stated objectives of a CCNE. The goal of this CCNE is to advance nanotechnology discoveries that have potential clinical utility for brain, pancreatic, and breast cancer detection, diagnosis, and treatment. Under the co-leadership of Chad A. Mirkin, who will drive the nanotechnology effort, and Steven Rosen, who will drive the clinical translational oncology effort, research is organized into five multidisciplinary teams. These teams are comprised of nanoscientists, cancer biologists, engineers, and clinicians with the goal of developing novel nanoscale technologies for ultimate development as cancer diagnostics, imaging agents, and therapeutics. Each project has a distinct focus and an industrial partner to promote the development of a platform for application in the clinic. To support these research goals, three Shared Resource Cores will be established: a Nanoconstructs Core to synthesize and characterize new nanotechnology constructs, which can feed into the primary projects and be tested in a common set of cell and animal models; a Bioinformatics Core to expand current biocomputing capabilities and to provide the capacity to utilize NCI online resources; and an Administrative Core to manage budgetary, administrative, and outreach matters. The NU-CCNE will promote collaborations not only across research projects within the center, but also Alliance-wide through pilot projects that will foster an environment where progress in one area could serve as a catalyst for progress in another. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=8710058

Related SciGraph Publications

  • 2016-10. Spherical nucleic acid targeting microRNA-99b enhances intestinal MFG-E8 gene expression and restores enterocyte migration in lipopolysaccharide-induced septic mice in SCIENTIFIC REPORTS
  • 2016-09. Pathways for Modulating Exosome Lipids Identified By High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1 in SCIENTIFIC REPORTS
  • 2015-12. Nanoparticle Targeting and Cholesterol Flux Through Scavenger Receptor Type B-1 Inhibits Cellular Exosome Uptake in SCIENTIFIC REPORTS
  • 2015-09. Self-Assembled Glycopeptide Nanofibers as Modulators of Galectin-1 Bioactivity in CELLULAR AND MOLECULAR BIOENGINEERING
  • 2015-03. The Powerful Functions of Peptide-Based Bioactive Matrices for Regenerative Medicine in ANNALS OF BIOMEDICAL ENGINEERING
  • 2015. Theranostic Magnetic Nanostructures (MNS) for Cancer in NANOTECHNOLOGY-BASED PRECISION TOOLS FOR THE DETECTION AND TREATMENT OF CANCER
  • 2015. Nanodiamond-Based Chemotherapy and Imaging in NANOTECHNOLOGY-BASED PRECISION TOOLS FOR THE DETECTION AND TREATMENT OF CANCER
  • 2014-08. Gradated assembly of multiple proteins into supramolecular nanomaterials in NATURE MATERIALS
  • 2013-12. Large-area molecular patterning with polymer pen lithography in NATURE PROTOCOLS
  • 2013-12. Desktop nanofabrication with massively multiplexed beam pen lithography in NATURE COMMUNICATIONS
  • 2013-06. A microfabricated platform for establishing oxygen gradients in 3-D constructs in BIOMEDICAL MICRODEVICES
  • 2013-06. Optimization of Pulsed-DEER Measurements for Gd-Based Labels: Choice of Operational Frequencies, Pulse Durations and Positions, and Temperature in APPLIED MAGNETIC RESONANCE
  • 2013-01. Estradiol promotes neural stem cell differentiation into endothelial lineage and angiogenesis in injured peripheral nerve in ANGIOGENESIS
  • 2012-12. CNS demyelination in fibrodysplasia ossificans progressiva in JOURNAL OF NEUROLOGY
  • 2012-08. Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex in JBIC JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
  • 2012-01. The properties and applications of nanodiamonds in NATURE NANOTECHNOLOGY
  • 2011-11. PSF Suppresses Tau Exon 10 Inclusion by Interacting with a Stem-Loop Structure Downstream of Exon 10 in JOURNAL OF MOLECULAR NEUROSCIENCE
  • 2011-02. Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy in PROTEIN & CELL
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "11537960"
        }, 
        "description": "Nanotechnology has enormous potential for creating innovative cancer diagnostics and therapeutics. This application proposes to establish a new Northwestern University (NU)-based CCNE comprised of a partnership between the Robert H. Lurie Comprehensive Cancer Center and the International Institute for Nanotechnology. This partnership will leverage and build upon significant existing resources, relationships, and traditions of cross-disciplinary collaborations. NU is one of the few universities with the required physical infrastructure and intellectual capacity, a demonstrated track record of research success and technology transfer in nanotechnology, and established links between nanoscientists and cancer researchers to successfully achieve the stated objectives of a CCNE. The goal of this CCNE is to advance nanotechnology discoveries that have potential clinical utility for brain, pancreatic, and breast cancer detection, diagnosis, and treatment. Under the co-leadership of Chad A. Mirkin, who will drive the nanotechnology effort, and Steven Rosen, who will drive the clinical translational oncology effort, research is organized into five multidisciplinary teams. These teams are comprised of nanoscientists, cancer biologists, engineers, and clinicians with the goal of developing novel nanoscale technologies for ultimate development as cancer diagnostics, imaging agents, and therapeutics. Each project has a distinct focus and an industrial partner to promote the development of a platform for application in the clinic. To support these research goals, three Shared Resource Cores will be established: a Nanoconstructs Core to synthesize and characterize new nanotechnology constructs, which can feed into the primary projects and be tested in a common set of cell and animal models; a Bioinformatics Core to expand current biocomputing capabilities and to provide the capacity to utilize NCI online resources; and an Administrative Core to manage budgetary, administrative, and outreach matters. The NU-CCNE will promote collaborations not only across research projects within the center, but also Alliance-wide through pilot projects that will foster an environment where progress in one area could serve as a catalyst for progress in another.", 
        "endDate": "2016-07-31T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2699098", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2699098"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "U54CA151880"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "nanotechnology discovery", 
          "progress", 
          "link", 
          "distinct focus", 
          "agents", 
          "Bioinformatics Core", 
          "enormous potential", 
          "potential clinical utility", 
          "Shared Resource Cores", 
          "primary project", 
          "pilot project", 
          "goal", 
          "research", 
          "NU-CCNE", 
          "Nu", 
          "project", 
          "novel", 
          "cells", 
          "engineers", 
          "NU)-based CCNE", 
          "diagnosis", 
          "stated objectives", 
          "intellectual capacity", 
          "breast cancer detection", 
          "physical infrastructure", 
          "clinic", 
          "catalyst", 
          "new Northwestern University", 
          "International Institute", 
          "Chad A. Mirkin", 
          "collaboration", 
          "Steven Rosen", 
          "clinicians", 
          "common set", 
          "significant existing resources", 
          "Robert H. Lurie Comprehensive Cancer Center", 
          "few universities", 
          "platform", 
          "capacity", 
          "CCNE", 
          "nanomaterials", 
          "nanotechnology efforts", 
          "environment", 
          "clinical translational oncology effort", 
          "Administrative Core", 
          "Cancer Diagnostics", 
          "partnership", 
          "cancer biologists", 
          "development", 
          "research goals", 
          "nanoscientists", 
          "current biocomputing capabilities", 
          "team", 
          "brain", 
          "animal models", 
          "nanoscale technologies", 
          "multidisciplinary team", 
          "alliance", 
          "new nanotechnology constructs", 
          "NCI online resources", 
          "tradition", 
          "technology transfer", 
          "therapeutics", 
          "area", 
          "innovative cancer diagnostics", 
          "Nanoconstructs Core", 
          "cancer researchers", 
          "research project", 
          "cross-disciplinary collaboration", 
          "research success", 
          "application", 
          "cancer diagnostics", 
          "treatment", 
          "co-leadership", 
          "Therapeutics", 
          "demonstrated track record", 
          "center", 
          "nanotechnology", 
          "outreach matters", 
          "industrial partners", 
          "pancreatic", 
          "ultimate development", 
          "relationship"
        ], 
        "name": "Nanomaterials for Cancer Diagnostics and Therapeutics", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.16753.36", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.16753.36", 
              "name": "NORTHWESTERN UNIVERSITY AT CHICAGO", 
              "type": "Organization"
            }, 
            "familyName": "MIRKIN", 
            "givenName": "CHAD A.", 
            "id": "sg:person.01332206101.44", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.01332206101.44", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2699098"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:08", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_20.xml.gz", 
        "startDate": "2010-09-21T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=8710058"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2699098'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2699098'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2699098'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2699098'


     

    This table displays all metadata directly associated to this object as RDF triples.

    127 TRIPLES      19 PREDICATES      105 URIs      97 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2699098 schema:about anzsrc-for:2211
    2 schema:amount N98d0f29a46374230937421a0c5f0488e
    3 schema:description Nanotechnology has enormous potential for creating innovative cancer diagnostics and therapeutics. This application proposes to establish a new Northwestern University (NU)-based CCNE comprised of a partnership between the Robert H. Lurie Comprehensive Cancer Center and the International Institute for Nanotechnology. This partnership will leverage and build upon significant existing resources, relationships, and traditions of cross-disciplinary collaborations. NU is one of the few universities with the required physical infrastructure and intellectual capacity, a demonstrated track record of research success and technology transfer in nanotechnology, and established links between nanoscientists and cancer researchers to successfully achieve the stated objectives of a CCNE. The goal of this CCNE is to advance nanotechnology discoveries that have potential clinical utility for brain, pancreatic, and breast cancer detection, diagnosis, and treatment. Under the co-leadership of Chad A. Mirkin, who will drive the nanotechnology effort, and Steven Rosen, who will drive the clinical translational oncology effort, research is organized into five multidisciplinary teams. These teams are comprised of nanoscientists, cancer biologists, engineers, and clinicians with the goal of developing novel nanoscale technologies for ultimate development as cancer diagnostics, imaging agents, and therapeutics. Each project has a distinct focus and an industrial partner to promote the development of a platform for application in the clinic. To support these research goals, three Shared Resource Cores will be established: a Nanoconstructs Core to synthesize and characterize new nanotechnology constructs, which can feed into the primary projects and be tested in a common set of cell and animal models; a Bioinformatics Core to expand current biocomputing capabilities and to provide the capacity to utilize NCI online resources; and an Administrative Core to manage budgetary, administrative, and outreach matters. The NU-CCNE will promote collaborations not only across research projects within the center, but also Alliance-wide through pilot projects that will foster an environment where progress in one area could serve as a catalyst for progress in another.
    4 schema:endDate 2016-07-31T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    6 schema:identifier N4854094ac4db45c8ab8577b0b81604da
    7 N7a7041962f4a4749bb132811b9403dae
    8 schema:inLanguage en
    9 schema:keywords Administrative Core
    10 Bioinformatics Core
    11 CCNE
    12 Cancer Diagnostics
    13 Chad A. Mirkin
    14 International Institute
    15 NCI online resources
    16 NU)-based CCNE
    17 NU-CCNE
    18 Nanoconstructs Core
    19 Nu
    20 Robert H. Lurie Comprehensive Cancer Center
    21 Shared Resource Cores
    22 Steven Rosen
    23 Therapeutics
    24 agents
    25 alliance
    26 animal models
    27 application
    28 area
    29 brain
    30 breast cancer detection
    31 cancer biologists
    32 cancer diagnostics
    33 cancer researchers
    34 capacity
    35 catalyst
    36 cells
    37 center
    38 clinic
    39 clinical translational oncology effort
    40 clinicians
    41 co-leadership
    42 collaboration
    43 common set
    44 cross-disciplinary collaboration
    45 current biocomputing capabilities
    46 demonstrated track record
    47 development
    48 diagnosis
    49 distinct focus
    50 engineers
    51 enormous potential
    52 environment
    53 few universities
    54 goal
    55 industrial partners
    56 innovative cancer diagnostics
    57 intellectual capacity
    58 link
    59 multidisciplinary team
    60 nanomaterials
    61 nanoscale technologies
    62 nanoscientists
    63 nanotechnology
    64 nanotechnology discovery
    65 nanotechnology efforts
    66 new Northwestern University
    67 new nanotechnology constructs
    68 novel
    69 outreach matters
    70 pancreatic
    71 partnership
    72 physical infrastructure
    73 pilot project
    74 platform
    75 potential clinical utility
    76 primary project
    77 progress
    78 project
    79 relationship
    80 research
    81 research goals
    82 research project
    83 research success
    84 significant existing resources
    85 stated objectives
    86 team
    87 technology transfer
    88 therapeutics
    89 tradition
    90 treatment
    91 ultimate development
    92 schema:name Nanomaterials for Cancer Diagnostics and Therapeutics
    93 schema:recipient N606ae8f29c044466b4b29d9a80113ab1
    94 sg:person.01332206101.44
    95 https://www.grid.ac/institutes/grid.16753.36
    96 schema:sameAs https://app.dimensions.ai/details/grant/grant.2699098
    97 schema:sdDatePublished 2019-03-07T12:08
    98 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    99 schema:sdPublisher Nafcf61df654a48b59d0f6969dc2da99a
    100 schema:startDate 2010-09-21T00:00:00Z
    101 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=8710058
    102 sgo:license sg:explorer/license/
    103 sgo:sdDataset grants
    104 rdf:type schema:MonetaryGrant
    105 N4854094ac4db45c8ab8577b0b81604da schema:name nih_id
    106 schema:value U54CA151880
    107 rdf:type schema:PropertyValue
    108 N606ae8f29c044466b4b29d9a80113ab1 schema:member sg:person.01332206101.44
    109 schema:roleName PI
    110 rdf:type schema:Role
    111 N7a7041962f4a4749bb132811b9403dae schema:name dimensions_id
    112 schema:value 2699098
    113 rdf:type schema:PropertyValue
    114 N98d0f29a46374230937421a0c5f0488e schema:currency USD
    115 schema:value 11537960
    116 rdf:type schema:MonetaryAmount
    117 Nafcf61df654a48b59d0f6969dc2da99a schema:name Springer Nature - SN SciGraph project
    118 rdf:type schema:Organization
    119 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    120 rdf:type schema:DefinedTerm
    121 sg:person.01332206101.44 schema:affiliation https://www.grid.ac/institutes/grid.16753.36
    122 schema:familyName MIRKIN
    123 schema:givenName CHAD A.
    124 rdf:type schema:Person
    125 https://www.grid.ac/institutes/grid.16753.36 schema:name NORTHWESTERN UNIVERSITY AT CHICAGO
    126 rdf:type schema:Organization
    127 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...